Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Suzanne Alolga"'
Autor:
Meryl Brod, Michael Højby Rasmussen, Suzanne Alolga, Jane F. Beck, Donald M. Bushnell, Kai Wai Lee, Aristides Maniatis
Publikováno v:
PharmacoEconomics - Open. 7:121-138
Autor:
Meryl, Brod, Michael Højby, Rasmussen, Suzanne, Alolga, Jane F, Beck, Donald M, Bushnell, Kai Wai, Lee, Aristides, Maniatis
Publikováno v:
PharmacoEconomics - open.
The aim was to evaluate the measurement properties of the Growth Hormone Deficiency-Child Treatment Burden Measure-Child (GHD-CTB-Child), a patient-reported outcome (PRO) for children aged 9 to13 years; the Growth Hormone Deficiency-Child Treatment B
Autor:
Donald M. Bushnell, Knud Vad, Michael Højby Rasmussen, Meryl Brod, Jacques Bedoin, Suzanne Alolga, Aristides Maniatis
Publikováno v:
PharmacoEconomics Open
Objective The aim of this study was to perform psychometric testing of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM): a patient-reported outcome (PRO) for children with GHD aged 9 to 0.70), as was test–retest reliability for the SWB,
Publikováno v:
Journal of the Endocrine Society
Background: Growth hormone deficiency treatment involves daily injections, which can be difficult to administer, incorporate into daily routines, and lead to poor treatment compliance. The Treatment Burden–Child Growth Hormone Deficiency (TB-CGHD)
Autor:
Jane F. Beck, Lars Wilkinson, Suzanne Alolga, Lise Højbjerre, Meryl Brod, Michael Højby Rasmussen
Publikováno v:
Quality of Life Research
Purpose Research demonstrates that children and adolescents with growth hormone deficiency (GHD) are impacted in multiple ways beyond their short stature; however, there are no disease-specific measures to assess these impacts. The purpose of this st
Publikováno v:
The Patient
Purpose The purpose of this study was to identify patient beliefs as well as clinical realities about insulin that may be barriers to type 2 diabetes patients initiating insulin treatment when recommended by their physician. This information was then
Autor:
Suzanne Alolga, Lars Wilkinson, Meryl Brod, Lise Højbjerre, Jane F. Beck, Michael Højby Rasmussen
Publikováno v:
The Patient
Objective Growth hormone deficiency (GHD) treatment for children requires growth hormone injections, typically administered daily until the child reaches adult height. Child GHD treatment burden is not well understood and no disease-specific measures